NAGE

NIAGEN BIOSCIENCE, INC.

NAGE · CIK 1386570 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$100M
20172024
Net Income$9M
20172024
Operating CF$12M
20172024
Free Cash Flow
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B—
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$0.11$-0.07$-0.24$-0.40———$-0.17
EPS (Diluted)$0.11$-0.07$-0.24$-0.40———$-0.17

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.1B
Current Assets$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$0.0B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.0B
Capital Expenditures—————$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$-0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B$0.0B
← Companies